JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

྾

Home
Compounds
ALA3275931

(2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-5-yl)methyl)-5-sec-butyl-1-((S)-2-((S)-1-carboxy-2-phenylethylcarbamoyl)pyrrolidin-1-yl)-14-(3-guanidinopropyl)-17-(2-hydroxy-3-oxo-2,4-diphenyl-2,3-dihydro-1H-pyrrol-1-yl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid

ID: ALA3275931

Chembl Id: CHEMBL3275931

PubChem CID: 90679288

Max Phase: Preclinical

Molecular Formula: C66H81N13O14

Molecular Weight: 1280.45

Molecule Type: Small molecule

Associated Items:

Bioactivity Summary Target Summary Assay Summary

Names and Identifiers

Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)N1C=C(c2ccccc2)C(=O)C1(O)c1ccccc1)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O

Standard InChI: InChI=1S/C66H81N13O14/c1-5-39(4)55(62(89)74-49(33-44-35-69-37-71-44)63(90)78-30-16-24-51(78)59(86)75-50(64(91)92)32-40-17-9-6-10-18-40)77-58(85)48(31-41-25-27-45(80)28-26-41)73-61(88)54(38(2)3)76-57(84)47(23-15-29-70-65(67)68)72-60(87)52(34-53(81)82)79-36-46(42-19-11-7-12-20-42)56(83)66(79,93)43-21-13-8-14-22-43/h6-14,17-22,25-28,35-39,47-52,54-55,80,93H,5,15-16,23-24,29-34H2,1-4H3,(H,69,71)(H,72,87)(H,73,88)(H,74,89)(H,75,86)(H,76,84)(H,77,85)(H,81,82)(H,91,92)(H4,67,68,70)/t39-,47-,48-,49-,50-,51-,52-,54-,55-,66?/m0/s1

Standard InChI Key: ATLXITDKIZNILM-YIFZSSHNSA-N

Alternative Forms

Parent:

ALA3275931
(3S)-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-o

Associated Targets(non-human)

AGTR1 Angiotensin II type 1a (AT-1a) receptor (1700 Activities)

Discover Target: AGTR1

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Molecule Features

Natural Product: No	Oral: No	Chemical Probe: No	Parenteral: No
Molecule Type: Small molecule	Topical: No	First In Class: No	Black Box: No
Chirality: No	Availability: No	Prodrug: No

Drug Indications

MESH ID	MESH Heading	EFO IDs	EFO Terms	Max Phase for Indication	References

Mechanisms of Action

Mechanism of Action	Action Type	target ID	Target Name	Target Type	Target Organism	Binding Site Name	References

Calculated Properties

Molecular Weight: 1280.45	Molecular Weight (Monoisotopic): 1279.6026	AlogP: ┄	#Rotatable Bonds: ┄
Polar Surface Area: ┄	Molecular Species: ┄	HBA: ┄	HBD: ┄
#RO5 Violations: ┄	HBA (Lipinski): ┄	HBD (Lipinski): ┄	#RO5 Violations (Lipinski): ┄
CX Acidic pKa: ┄	CX Basic pKa: ┄	CX LogP: ┄	CX LogD: ┄
Aromatic Rings: ┄	Heavy Atoms: ┄	QED Weighted: ┄	Np Likeness Score: ┄

References

1. Galardy RE, Stafford SS, Schaefer ML, Ho H, La Vorgna KA, Jamieson JD.. (1978) Biologically active derivatives of angiotensin for labeling cellular receptors., 21 (12): [PMID:214560] [10.1021/jm00210a020]

Source

Source(1):

Scientific Literature